SE8303012L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8303012L
SE8303012L SE8303012A SE8303012A SE8303012L SE 8303012 L SE8303012 L SE 8303012L SE 8303012 A SE8303012 A SE 8303012A SE 8303012 A SE8303012 A SE 8303012A SE 8303012 L SE8303012 L SE 8303012L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
cellulose derivative
composition
salbutamol
stimulant
Prior art date
Application number
SE8303012A
Other languages
Unknown language ( )
English (en)
Other versions
SE454946B (sv
SE8303012D0 (sv
Inventor
J M Padfield
C V Groom
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8303012D0 publication Critical patent/SE8303012D0/sv
Publication of SE8303012L publication Critical patent/SE8303012L/sv
Publication of SE454946B publication Critical patent/SE454946B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8303012A 1982-05-27 1983-05-27 Vattendispersion av salbutamol och ett cellulosaderivat SE454946B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8215502 1982-05-27

Publications (3)

Publication Number Publication Date
SE8303012D0 SE8303012D0 (sv) 1983-05-27
SE8303012L true SE8303012L (sv) 1983-11-28
SE454946B SE454946B (sv) 1988-06-13

Family

ID=10530673

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303012A SE454946B (sv) 1982-05-27 1983-05-27 Vattendispersion av salbutamol och ett cellulosaderivat

Country Status (25)

Country Link
JP (1) JPH0629181B2 (sv)
AT (1) AT390191B (sv)
AU (1) AU567675B2 (sv)
BE (1) BE896870A (sv)
CA (1) CA1203176A (sv)
CH (1) CH656308A5 (sv)
DE (1) DE3319356C2 (sv)
DK (1) DK167558B1 (sv)
ES (1) ES522752A0 (sv)
FI (1) FI81257C (sv)
FR (1) FR2527442B1 (sv)
GR (1) GR82681B (sv)
IE (1) IE55139B1 (sv)
IL (1) IL68805A0 (sv)
IT (1) IT1174759B (sv)
LU (1) LU84828A1 (sv)
MY (1) MY8700275A (sv)
NL (1) NL192663C (sv)
NO (1) NO163166C (sv)
NZ (1) NZ204385A (sv)
PH (1) PH19601A (sv)
PT (1) PT76773B (sv)
SE (1) SE454946B (sv)
ZA (1) ZA833854B (sv)
ZW (1) ZW11883A1 (sv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624213A (en) * 1963-10-30 1971-11-30 Merck & Co Inc Method of sterilizing aqueous pharmaceutical solutions employing propylene oxide and entrained air
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1453034A (en) * 1972-12-15 1976-10-20 Boehringer Sohn Ingelheim Pharmaceutical composition for treating spasticity
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung

Also Published As

Publication number Publication date
NZ204385A (en) 1986-07-11
BE896870A (fr) 1983-11-28
PT76773A (en) 1983-06-01
FR2527442B1 (fr) 1987-07-17
DK241783D0 (da) 1983-05-27
IE831267L (en) 1983-11-27
DE3319356C2 (de) 1996-07-04
NO831875L (no) 1983-11-28
AU567675B2 (en) 1987-12-03
DK167558B1 (da) 1993-11-22
NO163166C (no) 1990-05-02
AU1503983A (en) 1983-12-01
LU84828A1 (fr) 1985-03-21
MY8700275A (en) 1987-12-31
IT8348384A0 (it) 1983-05-27
NO163166B (no) 1990-01-08
JPH0629181B2 (ja) 1994-04-20
JPS591411A (ja) 1984-01-06
PT76773B (en) 1986-03-27
SE454946B (sv) 1988-06-13
FI81257B (fi) 1990-06-29
FI831893L (fi) 1983-11-28
PH19601A (en) 1986-05-27
ES8502336A1 (es) 1985-01-01
IT1174759B (it) 1987-07-01
FI831893A0 (fi) 1983-05-27
CH656308A5 (fr) 1986-06-30
FI81257C (sv) 1990-10-10
CA1203176A (en) 1986-04-15
NL8301900A (nl) 1983-12-16
ZW11883A1 (en) 1984-12-19
DE3319356A1 (de) 1983-12-01
DK241783A (da) 1983-11-28
AT390191B (de) 1990-03-26
IE55139B1 (en) 1990-06-06
ZA833854B (en) 1985-01-30
IL68805A0 (en) 1983-09-30
NL192663B (sv) 1997-08-01
ATA195283A (de) 1989-09-15
ES522752A0 (es) 1985-01-01
GR82681B (sv) 1985-02-07
SE8303012D0 (sv) 1983-05-27
NL192663C (nl) 1997-12-02
FR2527442A1 (fr) 1983-12-02

Similar Documents

Publication Publication Date Title
SE8406081L (sv) Sett och komposition for framstellning av farmaceutiska preparat for oral administrering och med kontrollerad langtidsverkan
SE8804629D0 (sv) New therapeutically active compounds
SE8700499D0 (sv) Novel pharmacologically active compounds
SE8402549D0 (sv) Substituerade moranolinderivat
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
SE8300623L (sv) Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin)
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
IL83044A0 (en) Diphenylpropanamines,their preparation and pharmaceutical compositions containing them
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
SE8804628D0 (sv) New compounds
NO870560L (no) Nytt farmasoeytisk preparat.
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
IT1196041B (it) Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
PT77309A (de) Isochinolinderivate verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
DK429480A (da) Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel
SE8303012D0 (sv) Farmaceutisk komposition
SE8004383L (sv) Farmaceutisk beredning for oral administrering och forfarande for dess framstellning
ES2064104T3 (es) Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral.
ATE15031T1 (de) 1-(2,4-dichlorphenoxy)-3-(3,4-dimethoxy-betaphenethylamino)-2-propanol, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
KR960007619A (ko) 신규 알긴산 유도체 및 그 제조방법
SE8704049D0 (sv) Novel pharmacological compounds

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8303012-2

Format of ref document f/p: F

NUG Patent has lapsed